HSCS
HeartSciences Inc.
Key Financials
Revenue
$4350
↓ 76.6%
Operating Income
$-8352571
↓ 32.5%
Gross Profit
$2470
↓ 80.3%
Net Income
$-8765229
↓ 32.7%
EPS (Diluted)
$-9.34
↑ 50.8%
Total Liabilities
$4.0M
↑ 83.8%
Shareholders' Equity
$205171.00
↓ 97.2%
Total Assets
$4.2M
↓ 55.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 6/26/2026 | View on SEC |
| 8-K | 6/26/2026 | View on SEC |
| DEFA14A | 6/26/2026 | View on SEC |
| DEFA14A | 6/26/2026 | View on SEC |
| DEFA14A | 6/25/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| DEFA14A | 6/24/2026 | View on SEC |
| SCHEDULE 13G | 6/24/2026 | View on SEC |
| DEFA14A | 6/23/2026 | View on SEC |
| 8-K | 6/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HSCS |
| Company Name | HeartSciences Inc. |
| CIK | 1468492 |
| Sector | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3842 |
| SIC Description | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Entity Type | operating |
| Fiscal Year End | 0430 |
| State of Incorporation | TX |
| Phone | 682-237-7781 |